Blair William & Co. IL trimmed its holdings in UpHealth, Inc. (NYSE:UPH – Get Rating) by 90.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,710 shares of the company’s stock after selling 177,390 shares during the quarter. Blair William & Co. IL owned 0.13% of UpHealth worth $32,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in UpHealth by 2.0% during the third quarter. Vanguard Group Inc. now owns 2,721,631 shares of the company’s stock valued at $1,448,000 after buying an additional 53,131 shares in the last quarter. State Street Corp increased its holdings in shares of UpHealth by 64.1% in the 1st quarter. State Street Corp now owns 611,221 shares of the company’s stock valued at $721,000 after purchasing an additional 238,655 shares during the period. IFP Advisors Inc increased its holdings in shares of UpHealth by 9.9% in the 4th quarter. IFP Advisors Inc now owns 242,000 shares of the company’s stock valued at $2,238,000 after purchasing an additional 21,800 shares during the period. Virtu Financial LLC increased its holdings in shares of UpHealth by 501.4% in the 1st quarter. Virtu Financial LLC now owns 205,534 shares of the company’s stock valued at $243,000 after purchasing an additional 171,360 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in shares of UpHealth by 39.9% in the 1st quarter. Bank of New York Mellon Corp now owns 147,521 shares of the company’s stock valued at $174,000 after purchasing an additional 42,106 shares during the period.
UpHealth Trading Down 3.1 %
NYSE:UPH opened at $1.55 on Friday. The stock’s 50 day moving average price is $1.66 and its 200 day moving average price is $2.18. UpHealth, Inc. has a 52 week low of $1.27 and a 52 week high of $9.50. The company has a market capitalization of $26.01 million, a P/E ratio of -0.11 and a beta of 0.67. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.64 and a current ratio of 0.64.
Wall Street Analyst Weigh In
Separately, Northland Securities upped their target price on UpHealth to $11.00 and gave the company an “outperform” rating in a report on Friday, March 3rd.
About UpHealth
UpHealth, Inc operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients.
Featured Stories
- Get a free copy of the StockNews.com research report on UpHealth (UPH)
- Trading Channel Breakout in Lululemon Brought by Earnings
- What Should Investors Make of These 3 Dividend Cuts?
- Constellation Brands Taps into Growth: Analysts Bullish on Stock
- CrowdStrike: Another Tech Stock to Buy on the DipĀ
- Salesforce: Time to Snap it Up as the Market Buys the Dip?
Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.